You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 91 No. 1, JANUARY 1953 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

ADRENOCORTICAL FUNCTION DURING CONTINUOUS LONGTERM THERAPY WITH CORTISONE

EPHRAIM P. ENGLEMAN, M.D.; MARCUS A. KRUPP, M.D.; HAROLD P. JOHNSON, Jr., M.D.; JOSEPH E. WELSH, M.D.; HAROLD T. WRENN, Ph.B.; WILBERT R. KING

AMA Arch Intern Med. 1953;91(1):1-7.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

SUPPRESSION of adrenocortical function and atrophy of the adrenal cortex have been described as following administration of cortisone.1 Both effects, presumably, are due to suppression of secretion of corticotropin, with resulting inac- tivity of the adrenal cortex. Thus, the use of cortisone in interrupted courses, or of cortisone and exogenous corticotropin in alternating courses, has been recommended in order to produce periodic reactivation of the adrenal cortex. Obviously it is important to know whether the suppression of adrenocortical-activity which results from long-term treatment with cortisone is reversible. A number of studies1 have suggested that this is the case, but this conclusion usually has been based on observations of patients who had received large doses of cortisone for relatively short periods. Furthermore, the eosinopenia following administration of corticotropin was often the sole criterion of adrenocortical responsiveness.

Formula

MATERIAL AND METHOD

The purpose of this study was to assess critically the . . . [Full Text PDF of this Article]


Author Affiliations

SAN FRANCISCO

From the Medical Service, Veterans Administration Hospital, and the Division of Medicine, University of California School of Medicine, and Stanford University School of Medicine.


Footnotes

Read before the meeting of the American Rheumatism Association, Chicago, June 6, 1952.

Reviewed in the Veterans Administration and published with the approval of the Chief Medical Director. The statements and conclusions published by the authors are the result of their own study and do not necessarily reflect the opinion or policy of the Veterans Administration.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1953 American Medical Association. All Rights Reserved.